Noni enhances the anticancer activity of cyclophosphamide and suppresses myelotoxicity and hepatotoxicity in tumor-bearing mice

CONCLUSIONS: The present study suggested that CYL treatment can cause serious myelotoxicity and hepatic injury in cancer patients. In conclusion, the combined use of noni with CYL potentially enhances the antitumor activity of CYL and suppresses myelotoxicity and hepatotoxicity induced by CYL in tumor-bearing mice.PMID:38662247 | DOI:10.1007/s00432-024-05734-1

Source: Clinical Genitourinary Cancer - April 25, 2024 Category: Cancer & Oncology Authors: Mohammad Ali S N Manjula Ishfaq Mohiuddin K Mruthunjaya Faiyaz Shakeel Suhail Ahmad Mir Shahid Ud Din Wani Source Type: research